| Commodity | Chronic risk assessment | Acute risk assessment | ||
|---|---|---|---|---|
| Input value (mg/kg) | Comment | Input value (mg/kg) | Comment | |
| RD‐RA 1: thiophanate‐methyl | ||||
| Grapefruits Oranges Mandarins | 0.28 | STMR × PF (0.11) (tentative) (scenario EU1) | 0.47 | HR × PF (0.11) (tentative) (scenario EU1) |
| – | No fall‐back GAP available scenario EU2/EU3) | – | No fall‐back GAP available (scenario EU2/EU3) | |
| Lemons | 0.28 | STMR × PF (0.11) (tentative) (scenario EU1) | 0.47 | HR × PF (0.11) (tentative) (scenario EU1) |
| – | No fall‐back GAP available (Scenario EU2) | – | No fall‐back GAP available (Scenario EU2) | |
| 0.28 | STMR × PF (0.11) (tentative) (Scenario EU3) | 0.47 | HR × PF (0.11) (tentative) (Scenario EU3) | |
| Limes | 0.28 | STMR × PF (0.11) (tentative) | 0.47 | HR × PF (0.11) (tentative) |
| Mangoes | 0.07 | 0.85a × STMR × PF (0.4) (tentative) (scenario EU1) | 0.20 | 0.85a × HR × PF (0.4) (tentative) (scenario EU1) |
| – | No fall‐back GAP available (scenario EU2/EU3) | – | No fall‐back GAP available (scenario EU2/EU3) | |
| Papaya | 0.34 | 0.85a × STMR (tentative) (scenario EU1) | 0.50 | 0.85a × HR (tentative) (scenario EU1) |
| – | No fall‐back GAP available (scenario EU2/EU3) | – | No fall‐back GAP available (scenario EU2/EU3) | |
| Okra, lady's fingers | 0.16 | 0.85a × STMR (tentative) | 0.41 | 0.85a × HR (tentative) |
| Swine, bovine and equine meat | 0.01* | STMR muscle (tentative) | 0.01* | HR muscle (tentative) |
| Swine, bovine and equine fat | 0.01* | STMR (tentative) | 0.01* | STMR (tentative) |
| Swine, bovine and equine liver | 0.01* | STMR (tentative) | 0.01* | STMR (tentative) |
| Swine, bovine and equine kidney | 0.01* | STMR (tentative) | 0.01* | STMR (tentative) |
| Cattle and horse milk | 0.01* | STMR (tentative) | 0.01* | STMR (tentative) |
| RD‐RA 2: carbendazim | ||||
| Grapefruit, Oranges | 0.04 | STMR CBZ × PF (0.47) (tentative) (scenario EU1) | 0.04 | HR CBZ × PF (0.47) (tentative) (scenario EU1) |
| – | No fall‐back GAP available (scenario EU2/EU3) | – | No fall‐back GAP Available (scenario EU2/EU3) | |
| Lemons | 0.12b | STMR CBZ × PF (0.47) (tentative) (scenario EU1/EU2) | 0.28b | HR CBZ × PF (0.47) (tentative) (scenario EU1/EU2) |
| 0.04 | STMR CBZ × PF (0.47) (tentative) (scenario EU3) | 0.04 | HR CBZ × PF (0.47) (tentative) (scenario EU3) | |
| Limes, Mandarins | 0.12b | STMR CBZ × PF (0.47) (tentative) | 0.28b | HR CBZ × PF (0.47) (tentative) |
| Mangoes | 0.06 | STMR TM × PF (0.4) × 0.15 × 0.56a + STMR CBZ × PF (0.4) (tentative) (scenario EU1) | 0.16 | HR TM × PF (0.4) × 0.15 × 0.56a + HR CBZ × PF (0.4) (tentative) (scenario EU1) |
| – | No fall‐back GAP available (scenario EU2/EU3) | – | No fall‐back GAP available (scenario EU2/EU3) | |
| Papaya | 0.11 | STMR TM × 0.15 × 0.56a + STMR CBZ (tentative) (scenario EU1) | 0.13 | HR TM × PF × 0.15 × 0.56a + HR CBZ (tentative) (scenario EU1) |
| – | No fall‐back GAP available (scenario EU2/EU3) | – | No fall‐back GAP available (scenario EU2/EU3) | |
| Okra, lady's fingers | 0.36 | STMR TM × 0.15 × 0.56a + STMR CBZ (tentative) | 0.91 | HR TM × 0.15 × 0.56a + HR CBZ (tentative) |
| RD‐RA 3: sum of carbendazim and 5‐hydroxy‐carbendazim, expressed as carbendazim | ||||
| Swine, bovine and equine meat | 0.02* | STMR muscle (tentative) | 0.02* | HR muscle (tentative) |
| Swine, bovine and equine fat | 0.02* | STMR (tentative) | 0.02* | STMR (tentative) |
| Swine, bovine and equine liver | 0.02* | STMR (tentative) | 0.02* | STMR (tentative) |
| Swine, bovine and equine kidney | 0.02* | STMR (tentative) | 0.02* | STMR (tentative) |
| RD‐RA 4: sum of carbendazim, 5‐hydroxy‐carbendazim and 4‐hydroxy‐carbendazim, expressed as carbendazim | ||||
| Cattle and horse milk | 0.02* | STMR (tentative) | 0.02* | STMR (tentative) |
*
Indicates that the input value is proposed at the limit of quantification.
TM: thiophanate‐methyl; CBZ: carbendazim.
a
Values derived from residue trials have been adjusted assuming that, following boiling/brewing/baking, thiophanate‐methyl would be reduced by 15% and converted into carbendazim. Additionally, thiophanate‐methyl residues were expressed as carbendazim considering that the ratio between the two molecular weights is 0.56.
b
Residues arising from the use of carbendazim.